The management of diabetes in terminal illness related to cancer

QJM: An International Journal of Medicine

Volumn 105, Issue 1, 2012, Pages 3-9

  King, E J ^a   Haboubi, H ^a   Evans, D ^a   Baker, I ^a   Bain, S C ^b   Stephens, J W ^a,b  

^a MORRISTON HOSPITAL   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; BIGUANIDE DERIVATIVE; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GLIBENCLAMIDE; GLICLAZIDE; GLIPIZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; LONG ACTING DRUG; METFORMIN; NATEGLINIDE; PIOGLITAZONE; REPAGLINIDE; ROSIGLITAZONE; SAXAGLIPTIN; SHORT ACTING DRUG; SITAGLIPTIN; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT; THIAZOLIDINE DERIVATIVE; VILDAGLIPTIN;

ABDOMINAL PAIN; ADVANCED CANCER; ALGORITHM; ANEMIA; ANOREXIA; BLOOD GLUCOSE MONITORING; CACHEXIA; CANCER PATIENT; COMORBIDITY; CONSENSUS; DRUG DOSE REDUCTION; DRUG HALF LIFE; DRUG MECHANISM; EDEMA; GASTROINTESTINAL SYMPTOM; GLYCEMIC CONTROL; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DYSFUNCTION; KIDNEY FAILURE; LIVER FAILURE; LIVER METABOLISM; MALABSORPTION; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PALLIATIVE THERAPY; PATIENT EDUCATION; PERIPHERAL EDEMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TERMINAL DISEASE; TREATMENT INDICATION; UPPER RESPIRATORY TRACT INFECTION; VOMITING;

EID: 83755195485     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcr167     Document Type: Review

References (20)

1. Gonzalez EL, Johansson S, Wallander MA, Rodriguez LA. Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 2009; 63:332-6.
2. Harris MI. Diabetes in America: epidemiology and scope of the problem. Diabetes Care 1998; 21(Suppl. 3):C11-4.
3. Department of Health. Health Survey for England, 2003 http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4098910.pdf. Accessed August 2011.
4. Dzien A, Dzien-Bischinger C, Lechleitner M. Fasting glucose and increasing age. Diabetes Obes Metab 2001; 3:297-8.
5. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005; 55:231-40.
6. Janssen-Heijnen ML, Maas HA, Houterman S, Lemmens VE, Rutten HJ, Coebergh JW. Comorbidity in older surgical cancer patients: influence on patient care and outcome. Eur J Cancer 2007; 43:2179-93.
7. Ko C, Chaudhry S. The need for a multidisciplinary approach to cancer care. J Surg Res 2002; 105:53-7.
8. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007; 50:1365-74.
9. Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 2007; 121:856-62.
10. Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005; 97:1679-87.
11. Ford-Dunn S, Smith A, Quin J. Management of diabetes during the last days of life: attitudes of consultant diabetologists and consultant palliative care physicians in the UK. Palliat Med 2006; 20:197-203.
12. Krolewski AS, Warram JH, Valsania P, Martin BC, Laffel LM, Christlieb AR. Evolving natural history of coronary artery disease in diabetes mellitus. Am J Med 1991; 90:56S-61.
13. Kilpatrick ES, Rigby AS, Atkin SL. The Diabetes control and complications trial: the gift that keeps giving. Nat Rev Endocrinol 2009; 5:537-45.
14. McCoubrie R, Jeffrey D, Paton C, Dawes L. Managing diabetes mellitus in patients with advanced cancer: a case note audit and guidelines. Eur J Cancer Care 2005; 14:244-8.
15. Poulson J. The management of diabetes in patients with advanced cancer. J Pain Symptom Manage 1997; 13:339-46.
16. Quinn K, Hudson P, Dunning T. Diabetes management in patients receiving palliative care. J Pain Symptom Manage 2006; 32:275-86.
17. Argiles JM, Busquets S, Toledo M, Lopez-Soriano FJ. The role of cytokines in cancer cachexia. Curr Opin Support Palliat Care 2009; 3:263-8.
18. Moldawer LL, Copeland EM, 3rd. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer 1997; 79:1828-39.
19. Alderman MH. New onset diabetes during antihypertensive therapy. Am J Hypertens 2008; 21:493-9.
20. Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, et al. Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med 2009; 361:1736-47.